CA-125 and RECIST: Key Insights in Ovarian Cancer
Recent advancements in the treatment of ovarian cancer have increasingly focused on understanding the recurrent patterns of the disease and ...
Tag: PARP inhibitors in cancer therapy
Talazoparib Benefits BRCA Mutant Metastatic Cancer
A recent multicenter retrospective study has cast new light on the therapeutic potential of talazoparib, a potent PARP inhibitor, in ...
NASP Controls Histone Turnover Behind PARP Resistance
The emergence of poly(ADP-ribose) polymerase inhibitors (PARPi) as a transformative therapy for homologous recombination-deficient tumors has significantly altered the landscape ...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!